African Adders: Partial Characterization of Snake Venoms from Three Bitis Species of Medical Importance and Their Neutralization by Experimental Equine Antivenoms

PLoS Neglected Tropical Diseases

Volumn 9, Issue 2, 2015, Pages

  Paixão Cavalcante, Danielle ^a   Kuniyoshi, Alexandre K ^a   Portaro, Fernanda C V ^a   da Silva, Wilmar Dias ^a   Tambourgi, Denise V ^a  

^a INSTITUTO BUTANTAN   (Brazil)

Author keywords

[No Author keywords available]

Indexed keywords

ANGIOTENSIN I; EQUIDAE VENOM ANTISERUM; GELATINASE; HYALURONIDASE; PHOSPHOLIPASE; PHOSPHOLIPASE A2; SERINE PROTEINASE; SNAKE VENOM; SNAKE VENOM ANTISERUM; UNCLASSIFIED DRUG; PROTEINASE INHIBITOR; VENOM ANTISERUM; VIPER VENOM;

ANTIBODY TITER; ARTICLE; BIOLOGICAL ACTIVITY; BITIS ARIETANS; BITIS GABONICA RHINOCEROS; BITIS NASICORNIS; BLOOD PRESSURE REGULATION; CONTROLLED STUDY; CROSS REACTION; ENVENOMATION; ENZYME ACTIVITY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; FIBRINOGENOLYSIS; FLUORESCENCE RESONANCE ENERGY TRANSFER; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; MALE; NONHUMAN; POLYACRYLAMIDE GEL ELECTROPHORESIS; PROTEIN CLEAVAGE; PROTEIN DEGRADATION; VIPERIDAE; WESTERN BLOTTING; ZYMOGRAPHY; AFRICA SOUTH OF THE SAHARA; ANIMAL; ANTAGONISTS AND INHIBITORS; ENZYMOLOGY; HORSE; HUMAN; METABOLISM;

AFRICA SOUTH OF THE SAHARA; ANIMALS; ANTIVENINS; CROSS REACTIONS; HORSES; HUMANS; PROTEASE INHIBITORS; VIPER VENOMS; VIPERIDAE;

EID: 84924084882     PISSN: 19352727     EISSN: 19352735     Source Type: Journal    
DOI: 10.1371/journal.pntd.0003419     Document Type: Article

References (48)

1. Kasturiratne A, Wickremasinghe AR, de Silva N, Gunawardena NK, Pathmeswaran A, et al. (2008) The global burden of snakebite: a literature analysis and modelling based on regional estimates of envenoming and deaths. PLoS Med 5: e218. doi: 10.1371/journal.pmed.0050218 18986210
2. Chippaux JP, (2010) Guidelines for the production, control and regulation of snake antivenom immunoglobulins. Biol Aujourdhui 204: 87–91. doi: 10.1051/jbio/2009043 20950580
3. Lenk P, Kalyabina S, Wink M, Joger U, (2001) Evolutionary relationships among the true vipers (Reptilia: Viperidae) inferred from mitochondrial DNA sequences. Mol Phylogenet Evol 19: 94–104. 11286494
4. Calvete JJ, Escolano J, Sanz L, (2007) Snake venomics of Bitis species reveals large intragenus venom toxin composition variation: application to taxonomy of congeneric taxa. J Proteome Res 6: 2732–2745. 17559253
5. Currier RB, Harrison RA, Rowley PD, Laing GD, Wagstaff SC, (2010) Intra-specific variation in venom of the African Puff Adder (Bitis arietans): Differential expression and activity of snake venom metalloproteinases (SVMPs). Toxicon 55: 864–873. doi: 10.1016/j.toxicon.2009.12.009 20026155
6. Lavonas EJ, Tomaszewski CA, Ford MD, Rouse AM, Kerns WP, (2002) Severe puff adder (Bitis arietans) envenomation with coagulopathy. J Toxicol Clin Toxicol 40: 911–918. 12507061
7. Marsh N, Glatston A, (1974) Some observations on the venom of the rhinoceros horned viper, Bitis nasicornis Shaw. Toxicon 12: 621–628. 4458120
8. Warrell DA, Ormerod LD, Davidson NM, (1975) Bites by puff-adder (Bitis arietans) in Nigeria, and value of antivenom. Br Med J 4: 697–700. 1203728
9. Laing GD, Renjifo JM, Ruiz F, Harrison RA, Nasidi A, et al. (2003) A new Pan African polyspecific antivenom developed in response to the antivenom crisis in Africa. Toxicon 42: 35–41. 12893059
10. Segura A, Villalta M, Herrera M, Leon G, Harrison R, et al. (2010) Preclinical assessment of the efficacy of a new antivenom (EchiTAb-Plus-ICP) for the treatment of viper envenoming in sub-Saharan Africa. Toxicon 55: 369–374. doi: 10.1016/j.toxicon.2009.08.010 19699756
11. Fasoli E, Sanz L, Wagstaff S, Harrison RA, Righetti PG, et al. (2010) Exploring the venom proteome of the African puff adder, Bitis arietans, using a combinatorial peptide ligand library approach at different pHs. J Proteomics 73: 932–942. doi: 10.1016/j.jprot.2009.12.006 20026262
12. Jennings BR, Spearman CW, Kirsch RE, Shephard EG, (1999) A novel high molecular weight fibrinogenase from the venom of Bitis arietans. Biochim Biophys Acta 1427: 82–91. 10082989
13. Nikai T, Momose M, Okumura Y, Ohara A, Komori Y, et al. (1993) Kallidin-releasing enzyme from Bitis arietans (puff adder) venom. Arch Biochem Biophys 307: 304–310. 8274016
14. Ohkura M, Miyashita Y, Nikai T, Suzuki J, Komori Y, et al. (1996) Properties of Ca++ release induced by puff adder lectin, a novel lectin from the snake Bitis arietans, in sarcoplasmic reticulum. J Pharmacol Exp Ther 277: 1043–1048. 8627515
15. Graham RL, McClean S, O’Kane EJ, Theakston D, Shaw C, (2005) Adenosine in the venoms from viperinae snakes of the genus Bitis: identification and quantitation using LC/MS and CE/MS. Biochem Biophys Res Commun 333: 88–94. 15935989
16. Vulfius CA, Gorbacheva EV, Starkov VG, Osipov AV, Kasheverov IE, et al. (2011) An unusual phospholipase A(2) from puff adder Bitis arietans venom -a novel blocker of nicotinic acetylcholine receptors. Toxicon 57: 787–793. doi: 10.1016/j.toxicon.2011.02.013 21333664
17. Huang TF, Wang WJ, Teng CM, Liu CS, Ouyang C, (1991) Purification and characterization of an antiplatelet peptide, arietin, from Bitis arietans venom. Biochim Biophys Acta 1074: 136–143. 2043663
18. Huang TF, Peng HC, Peng IS, Teng CM, Ouyang C, (1992) An antiplatelet peptide, gabonin, from Bitis gabonica snake venom. Arch Biochem Biophys 298: 13–20. 1524422
19. Maita N, Nishio K, Nishimoto E, Matsui T, Shikamoto Y, et al. (2003) Crystal structure of von Willebrand factor A1 domain complexed with snake venom, bitiscetin: insight into glycoprotein Ib alpha binding mechanism induced by snake venom proteins. J Biol Chem 278: 37777–37781. 12851390
20. Araujo MC, Melo RL, Cesari MH, Juliano MA, Juliano L, et al. (2000) Peptidase specificity characterization of C- and N-terminal catalytic sites of angiotensin I-converting enzyme. Biochemistry 39: 8519–8525. 10913258
21. Guidolin RG, Marcelino RM, Gondo HH, Morais JF, Ferreira RA, et al. (2010) Polyvalent horse F(Ab`)2 snake antivenom: Development of process to produce polyvalent horse F(Ab`)2 antibodies anti-african snake venom. African Journal of Biotechnology 9: 2446–2455
22. Pukrittayakamee S, Warrell DA, Desakorn V, McMichael AJ, White NJ, et al. (1998) The hyaluronidase activities of some Southeast Asian snake venoms. Toxicon 26: 629–637.
23. Kleiner DE, Stetler-Stevenson WG, (1994) Quantitative zymography: detection of picogram quantities of gelatinases. Anal Biochem 218: 325–329. 8074288
24. Irimura T, Nicolson GL, (1983) Interaction of pokeweed mitogen with poly(N-acetyllactosamine)-type carbohydrate chains. Carbohydr Res 120: 187–195. 6688756
25. Goldstein IJ, (1975) Studies on the combining sites of concanavalin A. Adv Exp Med Biol 55: 35–53. 1155247
26. Stock RP, Massoug Bodji A, Alagón A, Chippaux JP, (2007) Bringing antivenoms to Sub-Saharan Africa. Nature Biotechnol 25: 173–177. 17287747
27. South African Vaccine Producers (SAVP). Available: http://www.savp.co.za/. Accessed 26 November 2014.
28. Application for inclusion of equine F(ab’)2 antivenoms in the WHO model list for essential medicines. Avaiable: http://archives.who.int/eml/expcom/expcom15/applications/newmed/equine/antivenoms.pdf. Accessed 26 November 2014.
29. Boche J, Chippaux JP, Courtois B, (1981) Biochemical variations of West African snake venoms. Bull Soc Pathol Exot Filiales 74: 356–366. 7285271
30. Gutiérrez JM, Lomonte B, (2013) Phospholipases A2: unveiling the secrets of a functionally versatile group of snake venom toxins. Toxicon 62: 27–39. doi: 10.1016/j.toxicon.2012.09.006 23025922
31. Kemparaju K, Girish KS, (2006) Snake venom hyaluronidase: a therapeutic target. Cell Biochem Funct 24: 7–12. 16245359
32. Sanchez EE, Hotle D, Rodriguez-Acosta A, (2011) Neutralization of Bitis parviocula (Ethiopian mountain adder) venom by the South African Institute of Medical Research (SAIMR) antivenom. Rev Inst Med Trop Sao Paulo 53: 213–217. 21915465
33. Sant’ Ana CD, Ticli FK, Oliveira LL, Giglio JR, Rechia CG, et al. (2008) BjussuSP-I: a new thrombin-like enzyme isolated from Bothrops jararacussu snake venom. Comp Biochem Physiol A Mol Integr Physiol 151: 443–454. 17466550
34. Makowski GS, Ramsby ML, (1998) Identification and partial characterization of three calcium- and zinc-independent gelatinases constitutively present in human circulation. Biochem Mol Biol Int 46: 1043–1053. 9861458
35. Kuniyoshi AK, Rocha M, Cajado Carvalho D, Juliano MA, Juliano Neto L, et al. (2012) Angiotensin-degrading serine peptidase: a new chymotrypsin-like activity in the venom of Bothrops jararaca partially blocked by the commercial antivenom. Toxicon 59: 124–131. doi: 10.1016/j.toxicon.2011.11.001 22093545
36. MacKay N, Ferguson JC, McNicol GP, (1970) Effects of the venom of the rhinoceros horned viper (Bitis nasicornis) on blood coagulation, platelet aggregation, and fibrinolysis. J Clin Pathol 23: 789–796. 4251326
37. Mebs D, Panholzer F, (1982) Isolation of a hemorrhagic principle from Bitis arietans (puff adder) snake venom. Toxicon 20: 509–512. 7080057
38. Shebuski RJ, Ramjit DR, Bencen GH, Polokoff MA, (1989) Characterization and platelet inhibitory activity of bitistatin, a potent arginine-glycine-aspartic acid-containing peptide from the venom of the viper Bitis arietans. J Biol Chem 264: 21550–21556. 2600082
39. Swenson S, Markland FS Jr, , (2005) Snake venom fibrin(ogen)olytic enzymes. Toxicon 45: 1021–1039. 15882884
40. Rau JC, Beaulieu LM, Huntington JA, Church FC, (2007) Serpins in thrombosis, hemostasis and fibrinolysis. J Thromb Haemost 5: 102–115. 17635716
41. Mosesson MW, (2005) Fibrinogen and fibrin structure and functions. J Thromb Haemost 3: 1894–1904. 16102057
42. Schaeffer RC Jr, Chilton SM, Carlson RW, (1985) Puff adder venom shock: a model of increased vascular permeability. J Pharmacol Exp Ther 233: 312–317. 3999022
43. Marsh N, Gattullo D, Pagliaro P, Losano G, (1997) The Gaboon viper, Bitis gabonica: hemorrhagic, metabolic, cardiovascular and clinical effects of the venom. Life Sci 61: 763–769. 9275005
44. Benter IF, Yousif MH, Dhaunsi GS, Kaur J, Chappell MC, et al. (2008) Angiotensin-(1–7) prevents activation of NADPH oxidase and renal vascular dysfunction in diabetic hypertensive rats. Am J Nephrol 28: 25–33. 17890855
45. Loscalzo J, (2001) Nitric oxide insufficiency, platelet activation, and arterial thrombosis. Circ Res 88: 756–762. 11325866
46. Daull P, Jeng A, Battistini B, (2007) Towards triple vasopeptidase inhibitors for the treatment of cardiovascular diseases. J Cardiovasc Pharmacol 50: 247–256. 17878751
47. Vaiyapuri S, Wagstaff SC, Watson KA, Harrison RA, Gibbins JM, et al. (2010) Purification and functional characterisation of rhiminopeptidase A, a novel aminopeptidase from the venom of Bitis gabonica rhinoceros. PLoS Negl Trop Dis 4: e796. doi: 10.1371/journal.pntd.0000796 20706583
48. Calvete JJ, Cid P, Sanz L, Segura A, Villalta M, et al. (2010) Antivenomic assessment of the immunological reactivity of EchiTAb-Plus-ICP, an antivenon for the treatment of sneakbite envenoming in Sub-Saharan Africa. Am J Trop Med Hyg 82: 1194–1201. doi: 10.4269/ajtmh.2010.09-0733 20519622